clofibric acid and etofibrate

clofibric acid has been researched along with etofibrate in 71 studies

Research

Studies (71)

Timeframe	Studies, this research(%)	All Research%
pre-1990	43 (60.56)	18.7374
1990's	20 (28.17)	18.2507
2000's	7 (9.86)	29.6817
2010's	1 (1.41)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aragones, MD; Armijo, M; Catalán, RE; Martinez, AM; Priego, JG	1
Catalan, RE; Maroto, ML; Piña, M; Priego, JG	2
Gustafson, A	1
Loewer, H; Mertz, DP; Suermann, I	1
Pfeiffer, M; Tilsner, V	1
Rahlfs, VW; Safer, A; Zimmermann, H	1
Burkard, M; Huth, K; Quack, G; Richter, CM; Wülfroth, P	1
Geró, S; Horváth, M; Jósfay, A; Mezey, Z; Nánay, I; Varsányi, M	1
Kłosiewicz-Latoszek, L; Szostak, WB	1
Betz, E; Quack, G	1
Basista, M; Bieroń, K; Czarnecka, H; Dembińska-Kieć, A; Grodzińska, L; Kedzior, A; Kostka-Trabka, E; Slawiński, M; Trabka, E; Zmuda, A	1
Ojeda, G; Portolés, A; Portolés, MP; Rojo, JM	1
Castro, M; Gómez-Coronado, D; Herrera, E; Lasunción, MA; Martín, A; Quack, G	1
Palmer, RH	1
Caslake, MJ; Cruickshank, A; Demant, T; Kilday, C; Packard, CJ; Series, JJ; Shepherd, J	1
Armijo Castro, F; Gutierrez Fuentes, JA; Pire Solis, I; Vazquez Lopez, F	1
Holm, E; Schatton, W	1
Betz, E; Hämmerle, H	1
Altmayer, P; Garrett, ER	2
Chasseaud, LF; Schatton, W; Taylor, T; Waller, AR	1
Bardosi, A; Goebel, HH; Scheidt, P	1
Goebel, KM; Hausmann, L; Kaffarnik, H; Schneider, J; Schubotz, R; Zöfel, P	1
Franceschini, G; Paoletti, R; Sirtori, CR	1
Bochenek, W; Słowińska, R; Unlot, J	1
Santafé Oroz, J; Segarra Domènech, J	1
Díaz Méndez, M; Priego, JG	1
Hoppe, HJ; Johnson, KI; Schatton, W	1
Degenring, FH; Hotz, W; Schatton, W	1
Schatton, W	1
Kaffarnik, H; Schneider, J; Schubotz, R; Zöfel, P	1
Lang, PD; Vollmar, J	1
Djaja, S; Machalke, K; Richter, E	1
Armijo, M; Ortega, MP; Priego, JG; Sunkel, C	1
Altomonte, L; De Cunto, F; Greco, AV; Mingrone, G; Negrini, A	1
Gardner, MR; Garrett, ER	1
von Bock und Polach, U	1
Udelhoven, P	1
Ewert, M; Nachev, P; Oelschläger, H; Rothley, D	1
Göhmann, E; Mertz, DP; Suermann, I	1
Altomonte, L; Ghirlanda, G; Greco, AV; Manna, R; Mingrone, G; Pala, MA; Rebuzzi, A	1
Steger, W	1
Füsgen, I; Summa, JD	1
Calder, D; Luley, C; Scheffler, W; Schilling, A; Schwartzkopff, W	1
Mertz, DP	1
Krüger, B	1
Bocos, C; Castro, M; Herrera, E; Orozco, E; Quack, G	1
Freyberger, H; Schatz, H; Schifferdecker, E	1
Wolf, HR	1
Banyai, M; Koller, E; Li, S; Pidlich, J; Pirker, W; Rauscha, F; Sinzinger, H; Virgolini, I; Yang, Q	1
Bocos, C; Castro, M; Herrera, E; Quack, G	1
Bartz, VT; Gatz, J; Schröter, C; Slotty, C; Töle, R; Wand, P	1
Kinscherf, R; Metz, J; Wülfroth, P	1
Almeida Pinto, LE; Cendoroglo, MS; da Rocha Martinez, TL; Duarte, M; Fonseca, FA; Novazzi, JP; Rabelo, LM	1
Benadé, AJ; Fincham, JE; Quack, G; Wülfroth, P	1
dos Santos, JE; Loures-Vale, AA; Martinez, TL; Novazzi, JP; Rabelo, LM	1
Sinzinger, H	1
Caramelli, B; Mansur, AP; Ramires, JA; Serrano, CV; Spósito, AC	1
Halle, M; Luley, C; Mayer, H; Orth, M	1
Chelstowski, K; Jastrzebska, M; Kopciewicz, J; Naruszewicz, M; Pieczul-Mróz, J; Torbus-Lisiecka, B	1
Maranhão, RC; Ramires, JA; Santos, RD; Spósito, AC; Vinagre, CG	1
Coelho, OR; Mansur, AP; Maranhão, RC; Ramires, JA; Rodrigues-Sobrinho, CR; Sposito, AC	1
Fenselau, S; Schrezenmeir, J; Steinmetz, A	1
Dietlein, M; Geiss, HC; Parhofer, KG	1
el-Gindy, A; Hadad, GM; Mahmoud, WM	1
Ravinder, V; Reddy, PM; Rohini, R; Sarangapani, M; Shanker, K	1
Emmerich, KH; Erbler, H; Goldsteine, J; Görtelmeyer, R; Klindzane, M; Poritis, N; Stelmane, I	1
Briel, M; Ferreira-González, I; Jakob, T; Nordmann, AJ; Schandelmaier, S	1

Reviews

5 review(s) available for clofibric acid and etofibrate

Article	Year
Effects of fibric acid derivatives on biliary lipid composition. The American journal of medicine, 1987, Nov-27, Volume: 83, Issue:5B Topics: Bezafibrate; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Double-Blind Method; Female; Fenofibrate; Fibric Acids; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Propionates; Random Allocation	1987
[Pharmacologic therapy of atherosclerosis (I). Current possibilities]. Medicina clinica, 1983, Nov-26, Volume: 81, Issue:17 Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Clofibrate; Clofibric Acid; Fenofibrate; Gemfibrozil; Glycosaminoglycans; Humans; Ion Exchange Resins; Lipoproteins; Nicotinic Acids; Pentanoic Acids; Probucol	1983
[Antilipemic agents and atherothrombosis. Effects of antilipemic agents on blood platelet function, coagulation and fibrinolysis]. Deutsche medizinische Wochenschrift (1946), 1998, Sep-18, Volume: 123, Issue:38 Topics: Anticholesteremic Agents; Antiporters; Arteriosclerosis; Bezafibrate; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Clinical Trials as Topic; Clofibric Acid; Fenofibrate; Fibrinolysis; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lovastatin; Niacin; Pravastatin; Risk Factors; Simvastatin; Thrombosis	1998
Treatment of dyslipoproteinemia in the metabolic syndrome. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2001, Volume: 109, Issue:4 Topics: Arteriosclerosis; Clofibric Acid; Coronary Disease; Diabetes Mellitus, Type 2; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Metabolic Syndrome	2001
Fibrates for primary prevention of cardiovascular disease events. The Cochrane database of systematic reviews, 2016, 11-16, Volume: 11 Topics: Atorvastatin; Bezafibrate; Cardiovascular Diseases; Clofibric Acid; Fenofibrate; Gemfibrozil; Humans; Hypolipidemic Agents; Middle Aged; Myocardial Infarction; Primary Prevention; Simvastatin; Stroke	2016

Trials

19 trial(s) available for clofibric acid and etofibrate

Article	Year
[Etofibrate and clofibrate in double blind study]. Deutsche medizinische Wochenschrift (1946), 1976, Jul-30, Volume: 101, Issue:31 Topics: Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Humans; Hypercholesterolemia; Nicotinic Acids; Placebos	1976
Effects of fibric acid derivatives on biliary lipid composition. The American journal of medicine, 1987, Nov-27, Volume: 83, Issue:5B Topics: Bezafibrate; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Double-Blind Method; Female; Fenofibrate; Fibric Acids; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Propionates; Random Allocation	1987
Influence of bezafibrate, fenofibrate, nicotinic acid and etofibrate on plasma high-density lipoprotein levels. The American journal of cardiology, 1983, Aug-22, Volume: 52, Issue:4 Topics: Adipose Tissue; Animals; Apolipoprotein C-II; Apolipoprotein C-III; Apolipoproteins; Apolipoproteins C; Bezafibrate; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Clofibric Acid; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipolysis; Lipoproteins, HDL; Niacin; Rats; Structure-Activity Relationship	1983
[Study of the antilipemic effect of etofibrate (Lipo-Merz)]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1983, Apr-25, Volume: 38, Issue:17 Topics: Adult; Aged; Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged	1983
[Pharmacology and mechanism of action of etofibrate]. Die Medizinische Welt, 1982, Sep-24, Volume: 33, Issue:38 Topics: Animals; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipids	1982
[Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias]. Therapie der Gegenwart, 1982, Volume: 121, Issue:5 Topics: Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Theophylline; Xanthinol Niacinate	1982
[Double-blind study of the therapeutic activity of a new hypolipemic drug: etofibrate]. La Clinica terapeutica, 1981, Jan-15, Volume: 96, Issue:1 Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Double-Blind Method; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Male; Middle Aged	1981
[Therapy of lipoproteinemia. Comparison between Lipo-Merz retard and a commercial combination drug]. Fortschritte der Medizin, 1980, May-15, Volume: 98, Issue:18 Topics: Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Drug Combinations; Drug Evaluation; Female; Humans; Hyperlipoproteinemias; Male; Middle Aged; Niacin; Nicotinic Acids; Triglycerides	1980
[An alternative in the therapy of primary hyperlipemias: etofibrate in depot preparations]. Medizinische Klinik, 1980, Nov-07, Volume: 75, Issue:23 Topics: Adolescent; Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Triglycerides	1980
Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia. Drugs under experimental and clinical research, 1994, Volume: 20, Issue:3 Topics: Cholesterol; Cholesterol, HDL; Clofibric Acid; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Single-Blind Method; Triglycerides	1994
[Long-term treatment of hyperlipoproteinemia with etofibrate]. Fortschritte der Medizin, 1993, Sep-10, Volume: 111, Issue:25 Topics: Clofibric Acid; Follow-Up Studies; Humans; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Lipids; Long-Term Care	1993
[Evaluation of efficacy and safety of etofibrate in primary hyperlipidemia. A multicenter study]. Arquivos brasileiros de cardiologia, 1996, Volume: 67, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cholesterol; Clofibric Acid; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Triglycerides	1996
Effect of niacin and etofibrate association on subjects with coronary artery disease and serum high-density lipoprotein cholesterol <35 mg/dl. The American journal of cardiology, 1999, Jan-01, Volume: 83, Issue:1 Topics: Anticholesteremic Agents; Cholesterol, HDL; Clofibric Acid; Coronary Disease; Delayed-Action Preparations; Drug Administration Schedule; Drug Synergism; Female; Humans; Lipids; Male; Middle Aged; Niacin; Time Factors; Treatment Outcome	1999
Hemostatic factors in hypertriglyceridemic men: effects of a fatty meal before and after triglyceride-lowering treatment with etofibrate. Thrombosis research, 1999, Jun-15, Volume: 94, Issue:6 Topics: Clofibric Acid; Dietary Fats; Double-Blind Method; Factor XII; Fasting; Hemostatics; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Peptide Fragments; Pilot Projects; Postprandial Period; Prothrombin; Time Factors	1999
Etofibrate decreases factor VII and fibrinogen levels in patients with polymetabolic syndrome. International journal of clinical pharmacology research, 1999, Volume: 19, Issue:1 Topics: Arteriosclerosis; Clofibric Acid; Diabetes Mellitus, Type 1; Factor VII; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pilot Projects; Risk Factors; Statistics, Nonparametric	1999
Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease. Atherosclerosis, 2001, Feb-01, Volume: 154, Issue:2 Topics: Anticholesteremic Agents; Biomarkers; Cholesterol; Cholesterol, HDL; Chylomicrons; Clofibric Acid; Coronary Disease; Cross-Over Studies; Double-Blind Method; Drug Interactions; Emulsions; Female; Humans; Injections, Intravenous; Lipolysis; Male; Middle Aged; Prognosis; Triglycerides	2001
Etofibrate but not controlled-release niacin decreases LDL cholesterol and lipoprotein (a) in type IIb dyslipidemic subjects. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2001, Volume: 34, Issue:2 Topics: Analysis of Variance; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Clofibric Acid; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoprotein(a); Male; Middle Aged; Niacin; Statistics, Nonparametric; Triglycerides	2001
Influence of etofibrate on LDL-subtype distribution in patients with diabetic dyslipoproteinemia. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2003, Volume: 111, Issue:6 Topics: Adult; Aged; Body Mass Index; Cholesterol; Cholesterol, HDL; Clofibric Acid; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Triglycerides	2003
[Efficacy and safety of etofibrate in patients with non-proliferative diabetic retinopathy]. Klinische Monatsblatter fur Augenheilkunde, 2009, Volume: 226, Issue:7 Topics: Administration, Oral; Adolescent; Adult; Aged; Clofibric Acid; Diabetic Retinopathy; Double-Blind Method; Female; Humans; Hypolipidemic Agents; Male; Middle Aged; Placebo Effect; Treatment Outcome; Young Adult	2009

Other Studies

48 other study(ies) available for clofibric acid and etofibrate

Article	Year
Effects of etofibrate, clofibrate and nicotinic acid on the cyclic AMP-protein kinase system in rats. General pharmacology, 1979, Volume: 10, Issue:6 Topics: Adipose Tissue; Animals; Clofibrate; Clofibric Acid; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Insulin; Liver; Male; Nicotinic Acids; Protein Binding; Protein Kinases; Rats	1979
Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in normolipemic rats. General pharmacology, 1979, Volume: 10, Issue:3 Topics: Animals; Cholesterol; Clofibrate; Clofibric Acid; Lipid Metabolism; Lipids; Lipoproteins; Liver; Male; Nicotinic Acids; Phospholipids; Rats	1979
Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in hyperlipidemic rats. General pharmacology, 1979, Volume: 10, Issue:4 Topics: Animals; Clofibrate; Clofibric Acid; Diet; Hypercholesterolemia; Hyperlipidemias; Lipid Metabolism; Liver; Male; Nicotinic Acids; Rats; Triglycerides	1979
Treatment of hyperlipoproteinemia type II with etofibrate. International journal of clinical pharmacology and biopharmacy, 1979, Volume: 17, Issue:12 Topics: Body Weight; Cholesterol; Clofibrate; Clofibric Acid; Glucose Tolerance Test; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Liver Function Tests; Male; Middle Aged; Nicotinic Acids; Time Factors	1979
[The range and lipid-lowering effect of etofibrate as a retard-preparation in patients with hyperlipoproteinemia type IIa (author's transl)]. Medizinische Klinik, 1979, Dec-21, Volume: 74, Issue:51-52 Topics: Adult; Aged; Anticholesteremic Agents; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged	1979
[Influence of etofibrate on plasmaviscosity in hyperlipoproteinemias (author's transl)]. Medizinische Klinik, 1978, Jan-13, Volume: 73, Issue:2 Topics: Blood Viscosity; Cholesterol; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipidemias; Male; Middle Aged; Triglycerides	1978
Etofibrate treatment alters low density lipoprotein susceptibility to lipid peroxidation. Drugs under experimental and clinical research, 1992, Volume: 18, Issue:11-12 Topics: Animals; Cholesterol, Dietary; Cholesterol, LDL; Clofibric Acid; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipid Peroxidation; Rabbits; Triglycerides	1992
The effect of some drugs on in vitro cellular immune reactions and on circulating immune complexes in patients with myocardial infarction. Journal of investigational allergology & clinical immunology, 1991, Volume: 1, Issue:6 Topics: Aged; Antigen-Antibody Complex; Aorta; Cell Migration Inhibition; Clofibric Acid; Cyclosporine; Female; Humans; Hypolipidemic Agents; Immunity, Cellular; In Vitro Techniques; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Nifedipine	1991
Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia. European journal of clinical pharmacology, 1991, Volume: 40, Issue:1 Topics: Adult; Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Colestipol; Female; Fenofibrate; Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Probucol	1991
[Lipid therapy with etofibrate. Reduction of multiple risk factors with an active substance. Report of an international seminar. 8-11 November 1989, Houston, Texas]. Fortschritte der Medizin. Supplement : die Kongressinformation fur die Praxis, 1990, Volume: 85 Topics: Clofibrate; Clofibric Acid; Humans; Hypolipidemic Agents	1990
Effect of etofibrate on the development and the regression of atheromas in a rabbit model of atherosclerosis. VASA. Zeitschrift fur Gefasskrankheiten, 1990, Volume: 19, Issue:2 Topics: Animals; Arteriosclerosis; Clofibrate; Clofibric Acid; Disease Models, Animal; Hypolipidemic Agents; Rabbits	1990
[Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans]. Fortschritte der Medizin, 1989, Jul-10, Volume: 107, Issue:20 Topics: Adult; Arteriosclerosis Obliterans; Cholesterol, HDL; Clofibrate; Clofibric Acid; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Hypolipidemic Agents; Male; Triglycerides	1989
Immunomodulatory activity of anti-atherogenic drugs: effects on blastogenesis, humoral response, delayed hypersensitivity and passive anaphylaxis by immune complexes. Immunopharmacology, 1985, Volume: 9, Issue:2 Topics: Anaphylaxis; Animals; Antibody Formation; Antigen-Antibody Complex; Arteriosclerosis; Clofibrate; Clofibric Acid; Cyclic AMP; Cyclic GMP; Female; Hypersensitivity, Delayed; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Niacin; Thiophenes; Ticlopidine	1985
Studies with etofibrate in the rat. Part I: Effects on glycerol, free fatty acid and triacylglycerol metabolism. Biochimica et biophysica acta, 1988, Nov-04, Volume: 963, Issue:1 Topics: Adipose Tissue; Animals; Clofibrate; Clofibric Acid; Fatty Acids, Nonesterified; Glycerol; Lipolysis; Lipoproteins, VLDL; Liver; Male; Palmitic Acid; Palmitic Acids; Rats; Rats, Inbred Strains; Triglycerides	1988
Influence of etofibrate on low density lipoprotein metabolism. Atherosclerosis, 1988, Volume: 69, Issue:2-3 Topics: Adult; Anticholesteremic Agents; Clofibrate; Clofibric Acid; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged	1988
Concentration of clofibric acid in blood after the administration of delayed-release form of etofibrate. International journal of clinical pharmacology, therapy, and toxicology, 1987, Volume: 25, Issue:1 Topics: Adult; Biotransformation; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Female; Humans; Kinetics; Male; Tablets, Enteric-Coated	1987
[Etofibrate in severe diet-refractory cases of hyperlipoproteinemia]. Fortschritte der Medizin, 1986, Apr-03, Volume: 104, Issue:13 Topics: Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Dietary Fats; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Triglycerides	1986
Effect of etofibrate and its metabolites on atheromas of rabbits and on smooth muscle cell cultures. Arzneimittel-Forschung, 1986, Volume: 36, Issue:1 Topics: Animals; Anticholesteremic Agents; Aorta; Arteriosclerosis; Carotid Arteries; Cell Division; Cells, Cultured; Cholesterol; Cholesterol, Dietary; Clofibrate; Clofibric Acid; Clone Cells; Electric Stimulation; Fibroblasts; Lipoproteins, HDL; Male; Muscle, Smooth, Vascular; Rabbits; Triglycerides	1986
Disposition of etofibrate, clofibric and nicotinic acid esters, and their products in dogs. Journal of pharmaceutical sciences, 1985, Volume: 74, Issue:3 Topics: Animals; Clofibrate; Clofibric Acid; Dogs; Esters; Half-Life; Hypolipidemic Agents; Injections, Intravenous; Kinetics; Male; Niacin; Solubility; Solvents; Time Factors	1985
Bioavailability studies of etofibrate in rhesus monkeys. Arzneimittel-Forschung, 1985, Volume: 35, Issue:2 Topics: Animals; Biological Availability; Clofibrate; Clofibric Acid; Drug Interactions; Female; Half-Life; Hypolipidemic Agents; Intestinal Absorption; Macaca mulatta; Niacin; Time Factors	1985
Mitochondrial myopathy--a result of clofibrate/etofibrate treatment? Case report. Acta neuropathologica, 1985, Volume: 68, Issue:2 Topics: Aged; Clofibrate; Clofibric Acid; Humans; Hypolipidemic Agents; Kearns-Sayre Syndrome; Male; Microscopy, Electron; Mitochondria, Muscle; Muscles; Muscular Diseases	1985
Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observations. Artery, 1980, Volume: 8, Issue:6 Topics: Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Creatine Kinase; Female; gamma-Glutamyltransferase; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Long-Term Care; Male; Middle Aged; Triglycerides; Uric Acid	1980
[Pharmacologic therapy of arteriosclerosis: current possibilities]. Medicina clinica, 1984, Oct-06, Volume: 83, Issue:10 Topics: Anticholesteremic Agents; Arteriosclerosis; Clofibrate; Clofibric Acid; Humans	1984
Relative bioavailability of etofibrate. A comparison of an acute and a new sustained release formulation. Arzneimittel-Forschung, 1984, Volume: 34, Issue:12 Topics: Adult; Biological Availability; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Humans; Hypolipidemic Agents; Kinetics; Male	1984
[Atherosclerosis treatment with etofibrate retard. New perspectives]. Fortschritte der Medizin, 1983, Aug-11, Volume: 101, Issue:30 Topics: Arteriosclerosis; Blood Glucose; Cholesterol; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Female; Hemodynamics; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Triglycerides; Uric Acid	1983
Plasmolysis, red blood cell partitioning, and plasma protein binding of etofibrate, clofibrate, and their degradation products. Journal of pharmaceutical sciences, 1983, Volume: 72, Issue:11 Topics: Animals; Blood Proteins; Chromatography, High Pressure Liquid; Clofibrate; Clofibric Acid; Dogs; Erythrocytes; Humans; Hydrolysis; In Vitro Techniques; Plasma; Protein Binding; Ultrafiltration	1983
[Longterm therapy and etofibrate (author's transl)]. MMW, Munchener medizinische Wochenschrift, 1980, Jan-18, Volume: 122, Issue:3 Topics: Anticholesteremic Agents; Blood Cell Count; Blood Glucose; Clofibrate; Clofibric Acid; Drug Administration Schedule; Drug Tolerance; Humans; Hyperlipoproteinemias; Triglycerides	1980
[Bezafibrate and delayed action etofibrate in hyperlipidemia]. Deutsche medizinische Wochenschrift (1946), 1983, Feb-25, Volume: 108, Issue:8 Topics: Bezafibrate; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Triglycerides	1983
Effects of etofibrate on platelet function: in vitro studies in human plasma. Thrombosis research, 1980, Aug-01, Volume: 19, Issue:3 Topics: Animals; Blood Platelets; Clofibrate; Clofibric Acid; Epoprostenol; Humans; Male; Malondialdehyde; Nicotinic Acids; Platelet Factor 3; Rats; Serotonin	1980
Predictions of stability in pharmaceutical preparations XIX: Stability evaluation and bioanalysis of clofibric acid esters by high-pressure liquid chromatography. Journal of pharmaceutical sciences, 1982, Volume: 71, Issue:1 Topics: Animals; Buffers; Chromatography, High Pressure Liquid; Clofibrate; Clofibric Acid; Dogs; Drug Stability; Humans; Hydrogen-Ion Concentration; Hydrolysis; In Vitro Techniques; Kinetics; Models, Chemical	1982
[Lowering lipids rapidly and permanently with etofibrate]. Medizinische Klinik, 1982, Jan-29, Volume: 77, Issue:3 Topics: Cholestyramine Resin; Clofibrate; Clofibric Acid; Dextrothyroxine; Humans; Hyperlipoproteinemias; Lipoproteins, HDL; Liver; Nicotinic Acids; Sitosterols	1982
[Lipid lowering improved? Therapeutic progress by using biological mechanisms]. Die Medizinische Welt, 1982, Sep-10, Volume: 33, Issue:36 Topics: Anticholesteremic Agents; Clofibrate; Clofibric Acid; Humans; Hyperlipoproteinemia Type II	1982
[What is important in therapy of hyperlipoproteinemia. Lipo-Merz retard (etofibrate) lowers the atherogenic index]. Fortschritte der Medizin, 1982, Sep-16, Volume: 100, Issue:35 Topics: Anticholesteremic Agents; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Humans; Hyperlipoproteinemias	1982
[Stability of antilipidemic etofibrate and its metabolites towards gastrointestinal and blood hydrolases (author's transl)]. Arzneimittel-Forschung, 1980, Volume: 30, Issue:6 Topics: Biotransformation; Clofibrate; Clofibric Acid; Digestive System; Drug Stability; Esterases; Humans; Hydrolases; Hypolipidemic Agents; Kinetics	1980
[Etofibrate lowers the atherosclerosis index]. Medizinische Klinik, 1981, Mar-13, Volume: 76, Issue:6 Topics: Arteriosclerosis; Clofibrate; Clofibric Acid; Humans; Lipids	1981
[Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)]. Minerva medica, 1980, Feb-11, Volume: 71, Issue:4 Topics: Adult; Aged; Bile; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipids; Male; Middle Aged	1980
The effect of etofibrate retard, bezafibrate and procetofen. Artery, 1980, Volume: 8, Issue:2 Topics: Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Lipoproteins; Male; Middle Aged; Patient Compliance; Propionates; Triglycerides	1980
[Clofibrate therapy in hypercholesterolemia. Reports on medium-long-term movements of HDL- cholesterol by the action of clofibrate]. Fortschritte der Medizin, 1980, Dec-04, Volume: 98, Issue:45 Topics: Adult; Bezafibrate; Clofibrate; Clofibric Acid; Drug Administration Schedule; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Male; Middle Aged	1980
Etofibrate therapy and effect of added low-dose cholestyramine in patients with combined hyperlipidaemia. International journal of clinical pharmacology research, 1994, Volume: 14, Issue:5-6 Topics: Adult; Aged; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibric Acid; Drug Synergism; Drug Therapy, Combination; Female; Fibrinogen; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoprotein(a); Male; Middle Aged; Practice Guidelines as Topic; Triglycerides	1994
Effect of etofibrate on bile production in the normolipidemic rat. General pharmacology, 1995, Volume: 26, Issue:3 Topics: Animals; Anticholesteremic Agents; Bile; Body Weight; Cholesterol; Clofibric Acid; Lipids; Male; Organ Size; Phospholipids; Rats; Rats, Sprague-Dawley; Triglycerides	1995
[Regression of hard exudates in diabetic background retinopathy in therapy with etofibrate antilipemic agent]. Medizinische Klinik (Munich, Germany : 1983), 1994, Nov-15, Volume: 89, Issue:11 Topics: Adult; Blood Glucose; Clofibric Acid; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fundus Oculi; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pilot Projects	1994
Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia. Atherosclerosis, 1993, Volume: 102, Issue:2 Topics: Adult; Anticholesteremic Agents; Apolipoproteins B; Blood Platelets; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Female; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; In Vitro Techniques; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Platelet Aggregation; Stimulation, Chemical	1993
Studies with etofibrate in the rat. Part II: A comparison of the effects of prolonged and acute administration on plasma lipids, liver enzymes and adipose tissue lipolysis. Biochimica et biophysica acta, 1993, Jul-01, Volume: 1168, Issue:3 Topics: Adipose Tissue; Animals; Body Weight; Clofibric Acid; Hypolipidemic Agents; Lipids; Lipolysis; Liver; Male; Organ Size; Rats; Rats, Sprague-Dawley; Subcellular Fractions; Time Factors	1993
Etofibrate suppresses neointima formation of the ballooned common carotid artery of rats. Naunyn-Schmiedeberg's archives of pharmacology, 1995, Volume: 352, Issue:4 Topics: Animals; Carotid Artery, Common; Cell Division; Clofibric Acid; DNA; Hypolipidemic Agents; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred Lew	1995
[Lipid changes of fibrinogen and of platelet aggregation induced by etofibrate]. Arquivos brasileiros de cardiologia, 1996, Volume: 66, Issue:1 Topics: Adult; Clofibric Acid; Female; Fibrinogen; Humans; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Platelet Aggregation	1996
Confirmation of efficacy of etofibrate against peripheral atherosclerosis in non-human primates which model human lesion types I-VII. Arzneimittel-Forschung, 1996, Volume: 46, Issue:5 Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Body Weight; Chlorocebus aethiops; Clofibric Acid; Coronary Vessels; Diet, Atherogenic; Eating; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Organ Size	1996
High performance liquid chromatographic determination of etofibrate and its hydrolysis products. Journal of pharmaceutical and biomedical analysis, 2007, Jan-04, Volume: 43, Issue:1 Topics: Calibration; Capsules; Chromatography, High Pressure Liquid; Clofibric Acid; Delayed-Action Preparations; Half-Life; Hydrogen-Ion Concentration; Hydrolysis; Hypolipidemic Agents; Indicators and Reagents; Kinetics; Magnetic Resonance Spectroscopy; Reference Standards; Reproducibility of Results; Solutions; Spectrophotometry, Infrared	2007
Substituted tertiary phosphine Ru(II) organometallics: catalytic utility on the hydrolysis of etofibrate in pharmaceuticals. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2008, Volume: 70, Issue:5 Topics: Catalysis; Chemical Phenomena; Chemistry, Physical; Clofibric Acid; Electrons; Hydrolysis; Organometallic Compounds; Pharmaceutical Preparations; Phosphines; Ruthenium Compounds; Spectrum Analysis	2008